Cargando…

Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis

BACKGROUND: One of the most commonly applied protectotype vaccination protocol against infectious bronchitis (IB) in broiler chickens in the EU is simultaneous or alternate use of Ma5 and 4/91 vaccine strains. After IB vaccination and infection, systemic and upper respiratory tract (URT), humoral an...

Descripción completa

Detalles Bibliográficos
Autores principales: Smialek, Marcin, Tykalowski, Bartlomiej, Dziewulska, Daria, Stenzel, Tomasz, Koncicki, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299672/
https://www.ncbi.nlm.nih.gov/pubmed/28178957
http://dx.doi.org/10.1186/s12917-017-0963-1
_version_ 1782506070891036672
author Smialek, Marcin
Tykalowski, Bartlomiej
Dziewulska, Daria
Stenzel, Tomasz
Koncicki, Andrzej
author_facet Smialek, Marcin
Tykalowski, Bartlomiej
Dziewulska, Daria
Stenzel, Tomasz
Koncicki, Andrzej
author_sort Smialek, Marcin
collection PubMed
description BACKGROUND: One of the most commonly applied protectotype vaccination protocol against infectious bronchitis (IB) in broiler chickens in the EU is simultaneous or alternate use of Ma5 and 4/91 vaccine strains. After IB vaccination and infection, systemic and upper respiratory tract (URT), humoral and cell-mediated immunity (CMI), are stimulated. The level of this stimulation correlates with the level of protection against IB. RESULTS: We’ve investigated the development of URT and systemic, cell-mediated and humoral immunity in commercial broiler chickens vaccinated with Ma5 and/or 4/91 strains at hatch day. We’ve demonstrated that the group vaccinated with Ma5 and 4/91 strain simultaneously developed the most desirable immunity which reflects the level of CD8(+) T cells stimulation in spleen and Harderian gland, as well as the level of IgA and IgY in URT washings and serum and their cross-reactivity with 7 IBV strains. CONCLUSIONS: Although we did not demonstrate directly why Ma5 + 4/91 protocol is so efficient it seems that it combines the benefits of monovalent vaccination with either Ma5 or 4/91 and while Ma5 seems to stimulate CMI more efficiently, the 4/91 strain generates a wider spectrum of immune system cross-reactivity and higher URT IgA production.
format Online
Article
Text
id pubmed-5299672
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52996722017-02-13 Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis Smialek, Marcin Tykalowski, Bartlomiej Dziewulska, Daria Stenzel, Tomasz Koncicki, Andrzej BMC Vet Res Research Article BACKGROUND: One of the most commonly applied protectotype vaccination protocol against infectious bronchitis (IB) in broiler chickens in the EU is simultaneous or alternate use of Ma5 and 4/91 vaccine strains. After IB vaccination and infection, systemic and upper respiratory tract (URT), humoral and cell-mediated immunity (CMI), are stimulated. The level of this stimulation correlates with the level of protection against IB. RESULTS: We’ve investigated the development of URT and systemic, cell-mediated and humoral immunity in commercial broiler chickens vaccinated with Ma5 and/or 4/91 strains at hatch day. We’ve demonstrated that the group vaccinated with Ma5 and 4/91 strain simultaneously developed the most desirable immunity which reflects the level of CD8(+) T cells stimulation in spleen and Harderian gland, as well as the level of IgA and IgY in URT washings and serum and their cross-reactivity with 7 IBV strains. CONCLUSIONS: Although we did not demonstrate directly why Ma5 + 4/91 protocol is so efficient it seems that it combines the benefits of monovalent vaccination with either Ma5 or 4/91 and while Ma5 seems to stimulate CMI more efficiently, the 4/91 strain generates a wider spectrum of immune system cross-reactivity and higher URT IgA production. BioMed Central 2017-02-08 /pmc/articles/PMC5299672/ /pubmed/28178957 http://dx.doi.org/10.1186/s12917-017-0963-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Smialek, Marcin
Tykalowski, Bartlomiej
Dziewulska, Daria
Stenzel, Tomasz
Koncicki, Andrzej
Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis
title Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis
title_full Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis
title_fullStr Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis
title_full_unstemmed Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis
title_short Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis
title_sort immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299672/
https://www.ncbi.nlm.nih.gov/pubmed/28178957
http://dx.doi.org/10.1186/s12917-017-0963-1
work_keys_str_mv AT smialekmarcin immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis
AT tykalowskibartlomiej immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis
AT dziewulskadaria immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis
AT stenzeltomasz immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis
AT koncickiandrzej immunologicalaspectsoftheefficiencyofprotectotypevaccinationstrategyagainstchickeninfectiousbronchitis